| abstract |
A process is provided for preparing chiral diol sulfones of the structure (I) where R3 is preferably (II) or (III) where R4a is preferably aryl such as phenyl, and R1a is preferably alkyl such as t-butyl, which are intermediates used in preparing HMG CoA reductase inhibitors. |